Advertisement

More articles from Correction

You have access
Correction to “Structure of the Complex of an Iminopyridinedione Protein Tyrosine Phosphatase 4A3 Phosphatase Inhibitor with Human Serum Albumin”
Molecular Pharmacology December 2020, 98 (6) 781; DOI: https://doi.org/10.1124/molpharm.120.000131err
You have access
Correction to “Insulin-Like Growth Factor-1 Receptor Signaling Increases the Invasive Potential of Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer Cells via Src-Focal Adhesion Kinase and Forkhead Box Protein M1”
Molecular Pharmacology December 2020, 98 (6) 761; DOI: https://doi.org/10.1124/mol.114.095380err
You have access
Correction to “Aryl Hydrocarbon Receptor Regulates Distinct Dioxin-Dependent and Dioxin-Independent Gene Batteries”
Molecular Pharmacology November 2006, 70 (5) 1840; DOI: https://doi.org/10.1124/mol.70.5.1840
You have access
Correction to “In silico simulation of inhibitor drug effects on nuclear factor--κB pathway dynamics”
Molecular Pharmacology September 2004, 66 (3) 770;
You have access
Correction to “Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers”
Molecular Pharmacology September 2004, 66 (3) 771;
You have access
Correction to “Ca²⁺ regulation of inositol 1,4,5-trisphosphate receptors: can Ca²⁺ function without calmodulin?”
Molecular Pharmacology September 2004, 66 (3) 772;
You have access

Molecular Pharmacology January 2000, 57 (1) 211;